BRPI0602496B8 - uso de inibidores de proteases isolados do triatoma infestans - Google Patents

uso de inibidores de proteases isolados do triatoma infestans

Info

Publication number
BRPI0602496B8
BRPI0602496B8 BRPI0602496A BRPI0602496A BRPI0602496B8 BR PI0602496 B8 BRPI0602496 B8 BR PI0602496B8 BR PI0602496 A BRPI0602496 A BR PI0602496A BR PI0602496 A BRPI0602496 A BR PI0602496A BR PI0602496 B8 BRPI0602496 B8 BR PI0602496B8
Authority
BR
Brazil
Prior art keywords
triatoma infestans
protease inhibitors
isolated
inhibitors isolated
factor xia
Prior art date
Application number
BRPI0602496A
Other languages
English (en)
Inventor
Sadae Tanaka Aparecida
Torres Nicolau De Campos Ivan
Original Assignee
Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Univ Federal De Sao Paulo Unifesp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp, Univ Federal De Sao Paulo Unifesp filed Critical Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp
Priority to BRPI0602496A priority Critical patent/BRPI0602496B8/pt
Publication of BRPI0602496A publication Critical patent/BRPI0602496A/pt
Publication of BRPI0602496B1 publication Critical patent/BRPI0602496B1/pt
Publication of BRPI0602496B8 publication Critical patent/BRPI0602496B8/pt

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)

Abstract

uso de inibidores de proteases isolados do triatoma infestans. a presente invenção se refere ao uso de inibidores seletivos para fator xiia obtidos a partir de uma biblioteca de mutantes de um inibidor de fator xiia isolado do barbeiro triatoma infestans para o tratamento de doenças hemorrágicas e trombolíticas, em métodos diagnósticos ou no recobrimento de tubulações e demais superfícies que compõem um sistema de circulação extracorpóreo.
BRPI0602496A 2006-07-03 2006-07-03 uso de inibidores de proteases isolados do triatoma infestans BRPI0602496B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0602496A BRPI0602496B8 (pt) 2006-07-03 2006-07-03 uso de inibidores de proteases isolados do triatoma infestans

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0602496A BRPI0602496B8 (pt) 2006-07-03 2006-07-03 uso de inibidores de proteases isolados do triatoma infestans

Publications (3)

Publication Number Publication Date
BRPI0602496A BRPI0602496A (pt) 2008-02-26
BRPI0602496B1 BRPI0602496B1 (pt) 2017-12-26
BRPI0602496B8 true BRPI0602496B8 (pt) 2021-05-25

Family

ID=39124765

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0602496A BRPI0602496B8 (pt) 2006-07-03 2006-07-03 uso de inibidores de proteases isolados do triatoma infestans

Country Status (1)

Country Link
BR (1) BRPI0602496B8 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2556116C2 (ru) * 2013-11-28 2015-07-10 Общество с ограниченной ответственностью "Гематологическая Корпорация" (ООО "ГемаКор") Высокоселективный ингибитор контактной активации на основе инфестина 4

Also Published As

Publication number Publication date
BRPI0602496B1 (pt) 2017-12-26
BRPI0602496A (pt) 2008-02-26

Similar Documents

Publication Publication Date Title
MX2019005150A (es) Inhibidores de la tirosina-cinasa de bruton.
MX2012004258A (es) Inhibidores de la tirosina quinasa de bruton.
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
NO20060332L (no) Korrosjonsinhibitorsystemer for lav-, moderat- og høytemperaturfluider samt metoder for fremstilling og anvendelse av disse
PH12014500122A1 (en) Inhibitors of bruton's tyrosine kinase
CL2010001483A1 (es) Compuestos derivados de 5-fenil-1h-piridin-2-ona y 6-fenil-2h-piridazin-3-ona, inhibidores de tirosina-quinasa (btk); composicion farmaceutica que comprende a dichos compuestos y su uso para el tratamiento de un estado patologico inflamatorio y/o autoinmune.
WO2008131047A3 (en) Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
MX386879B (es) Sistemas de fluidos de punto de cuidado y usos de los mismos.
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
PA8782201A1 (es) Anticuerpo humanizados contra el globulómero ab(20-42) y sus usos
AR054233A1 (es) Composiciones de anticuerpos igg2
BR112013014418A2 (pt) processo e fluido para o tratamento de uma formação que contém ilita
EA200900091A1 (ru) Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
NO20084320L (no) Antistoffer mot EGFL7 og fremgangsmater for anvendelse av disse
CY1117328T1 (el) Διαδικασια για την παρασκευη πολυσιαλικου οξεος υψηλης καθαρiοτητας
CL2007003540A1 (es) Compuestos derivados de macrociclos, inhibidores de la proteasa serina de hepatitis c; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c.
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
EA200970164A1 (ru) Ингибиторы каспазы на основе пиридазинонового каркаса
BRPI0622083A2 (pt) Método e aparelho destinados à fabricação de substratos purificados ou substratos puros que são adicionalmente processados.
NO20080781L (no) GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer
DK2041181T3 (da) Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi
WO2009004094A3 (en) Compounds and methods for the treatment of renal disease
BRPI0602496B8 (pt) uso de inibidores de proteases isolados do triatoma infestans
UA96269C2 (uk) Інгібітори цистеїнпротеази та їх терапевтичне застосування

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2157 DE 08/05/2012.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AOS DESPACHOS PUBLICADOS NA RPI 2157 DE 08/05/2012 E RPI 2179 DE 09/10/2012.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/12/2017, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/07/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF